A study for a 59 year old woman who takes Toprol-Xl, Requip, Metformin, Synthroid, Neurontin - from FDA reports
107 females aged 59 (±5) who take the same drugs are studied. This is a personalized study for a 59 year old female patient who has Tachycardia, Diabetes, Restless Legs, Hypothyroid, Diabetic Neuropathy. The study is created by eHealthMe based on reports from FDA.
How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.
Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).
107 females aged 59 (±5) who take Toprol-Xl, Requip, Metformin, Synthroid, Neurontin are studied.
Number of reports submitted per year:
Information of the patient in this study:
- Age: 59
- Gender: female
- Conditions: Tachycardia, Diabetes, Restless Legs, Hypothyroid, Diabetic Neuropathy
- Drugs taken:
- Toprol-Xl (metoprolol succinate)
- Metformin (metformin hydrochloride)
- Requip (ropinirole hydrochloride)
- Synthroid (levothyroxine sodium)
- Neurontin (gabapentin)
eHealthMe real world results:
Comparison with this patient's adverse outcomes:
- Hyperreflexia(overactive or over responsive reflexes): 0 (0% of females aged 59 (±5) who take the drugs)
As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea
- Hyperreflexia in Tachycardia (a heart rate that exceeds the range of 100 beats/min): 0 (0% of females aged 59 (±5) who have Tachycardia)
- Hyperreflexia in Diabetes : 2 (0.01% of females aged 59 (±5) who have Diabetes)
- Hyperreflexia in Restless Legs : 0 (0% of females aged 59 (±5) who have Restless Legs)
- Hyperreflexia in Hypothyroid : 4 (0.04% of females aged 59 (±5) who have Hypothyroid)
- Hyperreflexia in Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 0 (0% of females aged 59 (±5) who have Diabetic Neuropathy)
As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea
- Hyperreflexia in Toprol-Xl: 0 (0% of females aged 59 (±5) who take Toprol-Xl)
- Hyperreflexia in Metformin: 4 (0.02% of females aged 59 (±5) who take Metformin)
- Hyperreflexia in Requip: 0 (0% of females aged 59 (±5) who take Requip)
- Hyperreflexia in Synthroid: 2 (0.01% of females aged 59 (±5) who take Synthroid)
- Hyperreflexia in Neurontin: 3 (0.03% of females aged 59 (±5) who take Neurontin)
Most common drug interactions over time
< 1 month:n/a
1 - 6 months:n/a
6 - 12 months:n/a
1 - 2 years:
- Renal impairment (severely reduced kidney function)
2 - 5 years:n/a
5 - 10 years:n/a
- Cardiac failure congestive
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Mitral valve incompetence (inefficient heart valve)
Top conditions involved for these people *:
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 14.02%
- High Blood Cholesterol : 15 people, 14.02%
- Depression : 11 people, 10.28%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 9.35%
- Stress And Anxiety : 9 people, 8.41%
Top co-used drugs for these people *:
- Nexium (23 people, 21.50%)
- Lantus (22 people, 20.56%)
- Lisinopril (21 people, 19.63%)
- Lipitor (20 people, 18.69%)
- Lyrica (18 people, 16.82%)
* Some reports may have incomplete information.
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
You are not alone:
What are the drugs?
- Toprol-xl has active ingredients of metoprolol succinate. It is often used in high blood pressure. (latest outcomes from Toprol-xl 40,326 users)
- Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. (latest outcomes from Requip 18,163 users)
- Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. (latest outcomes from Metformin 248,689 users)
- Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. (latest outcomes from Synthroid 166,728 users)
- Neurontin has active ingredients of gabapentin. It is often used in neuralgia. (latest outcomes from Neurontin 88,847 users)
What are the conditions?
- Tachycardia (a heart rate that exceeds the range of 100 beats/min) can be treated by Atenolol, Metoprolol tartrate, Flecainide acetate, Toprol-xl, Bisoprolol fumarate (latest reports from 106,235 Tachycardia patients)
- Diabetes can be treated by Metformin, Metformin hydrochloride, Lantus, Januvia, Glipizide (latest reports from 321,553 Diabetes patients)
- Restless legs can be treated by Mirapex, Requip, Ropinirole hydrochloride, Pramipexole dihydrochloride, Gabapentin (latest reports from 30,911 Restless legs patients)
- Hypothyroid can be treated by Synthroid, Levothyroxine sodium, Levothyroxine thyroid, Levoxyl, Levothroid (latest reports from 101,072 Hypothyroid patients)
- Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus) can be treated by Gabapentin, Lyrica, Neurontin, Cymbalta, Amitriptyline hydrochloride (latest reports from 15,404 Diabetic neuropathy patients)
What are the symtoms?
- Hyperreflexia (overactive or over responsive reflexes) has been reported by people with depression, multiple sclerosis, pain, bipolar disorder, stress and anxiety (latest reports from 3,148 Hyperreflexia patients).
Could your drugs cause:
Could your conditions cause:
- Toprol-xl and Requip drug interaction (312 reports)
- Toprol-xl and Metformin drug interaction (1,848 reports)
- Toprol-xl and Synthroid drug interaction (3,252 reports)
- Toprol-xl and Neurontin drug interaction (1,719 reports)
- Requip and Metformin drug interaction (779 reports)
- Requip and Synthroid drug interaction (1,185 reports)
- Requip and Neurontin drug interaction (1,039 reports)
- Metformin and Synthroid drug interaction (8,117 reports)
- Metformin and Neurontin drug interaction (3,824 reports)
- Synthroid and Neurontin drug interaction (6,018 reports)
Related publications that referenced our studies
- Wiwanitkit S, Wiwanitkit V, "Metformin and sleep disorders", Indian journal of endocrinology and metabolism, 2012 Jan .
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
- ŽUPANIĆ KRMEK DU, BRAJKOVIĆ I, BEKIĆ D, KRNIĆ A, JURKOVIĆ P, PAVLOVIĆ T, "CALCIFIED DEEP VEIN THROMBOSIS IN A PATIENT WITH RECURRENT DEEP VEIN THROMBOSIS AND SARCOIDOSIS", Acta Medica Croatica, 2014 Mar .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2017 Jan .
- Lee IS, Kim KS, Kim KH, Park J, Jeong HS, Kim Y, Na YC, Chung WS, Ahn KS, Lee SG, Um JY, "Antihyperglycemic and Antiobesity Effects of JAL2 on db/db Mice", Evidence-Based Complementary and Alternative Medicine, 2016 Mar .
- Will you have Extrapyramidal Disorder with Colchicine?
- Will you have Hyperhidrosis with Tylenol?
- Will you have Perspiration - Excessive with Tylenol?
- Will you have Diaphoresis with Tylenol?
- Will you have Sweating - Excessive with Tylenol?
- Will you have Amyotrophic Lateral Sclerosis with Doxycycline?
- Will you have Lou Gehrig'S Disease with Doxycycline?
- Will you have Als with Doxycycline?
- Will you have Gastrointestinal Oedema with Fluoxetine?
- Will you have Coughing with Chills?
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.